Accelerated Access Review

{{Use dmy dates|date=August 2019}}

The Accelerated Access Review was an initiative commissioned by the government of the United Kingdom,{{Cite web|url=https://www.gov.uk/government/publications/accelerated-access-review-final-report|title=Accelerated Access Review: final report|website=GOV.UK|language=en|access-date=2019-09-10}} working with the Department of Health. The Accelerated Access Review aimed to speed up access to innovative drugs, devices and diagnostics for NHS patients. The Accelerated Access Review was commissioned by the government in November 2014, and produced its final report in October 2016.{{Cite web|url=http://www.pharmatimes.com/news/govt_publishes_findings_of_accelerated_access_review_1174383|title=Gov’t publishes findings of Accelerated Access Review|last=McKee|first=Selina|date=2016-10-24|website=www.pharmatimes.com|language=en|access-date=2017-07-28}}{{Cite web|url=http://www.nhsconfed.org/resources/2016/11/accelerated-access-review-report-released|title=Accelerated Access Review report released|date=1 November 2016|website=www.nhsconfed.org|language=en|access-date=2017-07-28}}